Swiss pharma manufacturing firm Lonza has secured £30m of funding through the UK government’s Life Sciences Innovative Manufacturing Fund to expand and relocate into a specialist life sciences campus.
EG revealed last year that the Basel-headquartered firm
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
